SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Institutional and real-world-asset adoption narrativesespecially reports that NYSE/ICE is testing Avalanche for 24/7 tokenized securities tradingare fueling AVAXs sharp rally and renewed altcoin-rotation speculation. Traders remain divided, with bulls citing stronger volume, technical breakouts and corporate partnerships while skeptics characterize the move as another pump-and-dump and point to weak follow-through and token-inflation concerns.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is drawing attention around its new CEO and the v5.0 mainnet upgrade, particularly post-quantum accounts, quantum-resistant security, and agentic-payment capabilities, as traders react to a rebound. Bulls view the technology and broader altcoin-cycle or regulatory tailwinds as potential catalysts, while bears cite dilution, weak adoption and revenue, and prolonged underperformance.

TRON is a decentralized blockchain-based operating system designed to accelerate the decentralization of the internet and its underlying infrastructure. It serves as a global settlement layer for stablecoins and everyday digital purchases, providing a high-throughput environment to support large-scale decentralized applications. The network is governed by a decentralized autonomous organization (DAO), which allows the community to manage the protocol without a central authority. Its primary value proposition includes a unique resource model that utilizes bandwidth and energy to allow for high transaction volumes without traditional fee spikes.  The platform functions as a smart contract platform that enables the creation of decentralized applications and is compatible with the Ethereum Virtual Machine, allowing developers to easily migrate applications. TRON operates using a Delegated Proof of Stake consensus mechanism where token holders vote for 27 Super Representatives to verify transactions and maintain the ledger. This structure is built for scalability and fast finality, aiming to handle more transactions per second than many established legacy blockchains. Users can interact with the ecosystem for various purposes, including decentralized finance (DeFi) through platforms like JustLend DAO and decentralized storage via the BitTorrent File System.  Value moves through the system via its native utility token, TRX, which facilitates transactions and grants users access to network resources. Holders can lock their TRX in a staking mechanism to gain TRON Power, which is used to vote on network rules and elect Super Representatives, earning rewards for securing the network. Established by the TRON Foundation and led by founder Justin Sun, the project has transitioned into a community-led DAO. The ecosystem is supported by strategic partnerships with major global entities, including Samsung, which integrated TRON into its blockchain keystore, as well as BitTorrent, Opera, and Swisscom Blockchain.

Tron

TRX is drawing attention for its resilient, steady uptrend and repeated technical-breakout discussions, with traders highlighting consolidation, higher highs, and relative strength during broader crypto volatility. Bullish commentary points to Trons heavy stablecoin-use and network activity, while bears warn that macro rate-hike concerns and a corrective pullback could limit the move.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Quarterly results and higher adjusted-EBITDA guidance, alongside a new multi-year DefenCath agreement with a large dialysis operator widely inferred to be DaVita, are driving attention. Traders view the expanded provider coverage and upcoming pilot as positive, while debate remains focused on post-TDAPA reimbursement, the anticipated revenue decline, and limited visibility into 2027.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Institutional adoption and tokenization remain the main focus, with traders highlighting Chainlinks role in connecting traditional finance, tokenized assets, stablecoins and blockchain networks, alongside speculation around broader regulatory clarity. The community is divided between bullish views that growing utility will eventually support LINK and criticism that tokenomics, supply and weak price performance prevent network adoption from translating into token value.

Marathon Petroleum Corp. engages in the refining, marketing, and transportation of petroleum products. It operates through the Refining and Marketing, and Midstream segments. The Refining and Marketing segment includes refining crude oil and other feedstocks, purchasing ethanol, and refined products for resale and distribution of refined products. The Midstream segment refers to transportation, storing, distribution, and marketing of crude oil and refined products. The company was founded in 1887 and is headquartered in Findlay, OH.

Marathon Petroleum Corp

MPC is drawing attention as U.S. refining stocks surge to repeated records on elevated crack spreads and fuel-supply concerns linked to geopolitical disruptions and refinery outages. Traders are broadly bullish on the margin-driven earnings and sector strength, though some warn the rally is overextended and vulnerable to a correction if spreads retreat or tensions ease.

iShares Ethereum Trust (The) - iShares Ethereum Trust ETF

iShares Ethereum Trust ETF

ETHA is drawing attention amid a sharp Ethereum-linked rebound, with traders highlighting bullish call activity, breakout setups and renewed ETF demand. Others remain cautious, citing outstanding put positioning, negative flows and the possibility that the move is only tentative dip-buying.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: PepsiCo Foods North America (PFNA), PepsiCo Beverages North America (PBNA), International Beverages Franchise (IB Franchise), Europe, Middle East and Africa (EMEA), Latin America Foods (LatAm Foods), and Asia Pacific Foods. The PFNA segment refers to the food businesses in the United States and Canada. The PBNA segment includes beverage businesses in the United States and Canada. The IB Franchise segment involves the international franchise beverage businesses, as well as the SodaStream business. The EMEA segment pertains to food businesses and beverage businesses with company-owned bottlers in Europe, the Middle East, and Africa. The LatAm Foods segment consists of food businesses in Latin America. The Asia Pacific Foods segment is associated in food businesses in Asia Pacific, including China, Australia and New Zealand, as well as India. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

Mixed quarterly results and a cautious outlook on North American demand are driving attention, with traders focused on weaker snack volumes, consumer budget pressure, margin concerns and the stocks slide toward multi-year lows. Some view the selloff as an attractive dividend/value entry, while others expect a deeper slowdown tied to pricing, GLP-1 adoption and changing consumer habits.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat is drawing attention after traders focused on its failure to place among the leading winners in the Armys Drone Dominance Gauntlet II, weakening expectations for near-term defense contracts. Bulls argue the company can still benefit from Black Widow, Blue Ops and future procurement, while bears point to limited confirmed orders, missed expectations and declining confidence in management.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

Unusually strong price and volume action without a confirmed company announcement has focused attention on IBRX, with traders speculating about institutional accumulation and short covering ahead of potential Anktiva label-expansion updates. Others attribute the move to options activity and recurring pump-and-dump volatility, underscoring the uncertainty around the rally.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AgomAb Therapeutics (NASDAQ:AGMB) Hits New 52-Week Low  - Here's What Happened

AgomAb Therapeutics (NASDAQ:AGMB) Hits New 52-Week Low - Time to Sell...

AgomAb Therapeutics NV's Quiet Period To Expire on March 18th (NASDAQ:AGMB)

AgomAb Therapeutics' (NASDAQ:AGMB - Get Free Report) quiet period is set to expire on Wednesday, March 18th. AgomAb Therapeutics had issued 12,500,000 shares in its IPO on February 6th. The total...

AgomAb Therapeutics (NASDAQ:AGMB) Raised to Hold at Zacks Research

Zacks Research raised AgomAb Therapeutics to a "hold" rating in a research report on Wednesday...

AgomAb Therapeutics (NASDAQ:AGMB) Stock Price Down 4.5% - Here's Why

AgomAb Therapeutics (NASDAQ:AGMB) Shares Down 4.5% - What's Next...

AgomAb Therapeutics (NASDAQ:AGMB) Sets New 1-Year High - Still a Buy?

AgomAb Therapeutics (NASDAQ:AGMB) Hits New 52-Week High - Here's What Happened...

AgomAb Therapeutics (NASDAQ:AGMB) Now Covered by Leerink Partners

Leerink Partners began coverage on AgomAb Therapeutics in a research note on Tuesday. They set an "outperform" rating and a $36.00 target price on the stock...

Morgan Stanley Initiates Coverage on AgomAb Therapeutics (NASDAQ:AGMB)

Morgan Stanley began coverage on shares of AgomAb Therapeutics in a report on Tuesday. They set an "overweight" rating and a $28.00 target price for the company...

AgomAb Therapeutics (NASDAQ:AGMB) Coverage Initiated by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. started coverage on shares of AgomAb Therapeutics in a report on Tuesday. They issued an "overweight" rating and a $32.00 target price on the stock...

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

AgomAb Therapeutics NV - ADR

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$12.17
Prev Close	$12.08
Open	$12.26
Dividend Yield	N/A
50-Day Moving Average	$13.28
Beta	0.41
Avg. Volume	127,975.15
PE Ratio	N/A

52-Week High	$17.82
52-Week Low	$8.75
Market Capitalization	$599.35M
EPS (Annual)	-$1.45
Price to Book	1.98
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

AGMB Fundamentals